3087 — Doutor Nichires Holdings Share Price
Last trade - 00:00- ¥137bn
- ¥108bn
- ¥159bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.06 | ||
| PEG Ratio (f) | 1.12 | ||
| EPS Growth (f) | 14.43% | ||
| Dividend Yield (f) | 2.34% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.25 | ||
| Price to Tang. Book | 1.26 | ||
| Price to Free Cashflow | 24.16 | ||
| Price to Sales | 0.83 | ||
| EV to EBITDA | 6.6 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.86% | ||
| Return on Equity | 8.06% | ||
| Operating Margin | 7.04% | ||
Financial Summary
| Year End 28th Feb | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 109,363 | 126,864 | 140,625 | 148,822 | 159,147 | 172,300 | 182,400 | 10.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +94.84 | +24.9 | +10.97 | +18.96 | +12.22 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Doutor Nichires Holdings Co Ltd is a Japan-based company mainly engaged in coffee bean procurement, roasting, processing and sales, restaurant operations, franchising, bakery operations and food sales. The Company has three business segments. Nippon Restaurant System Group segment operates restaurant chains, including Hoshino Coffee and Yomenya Goemon, and engages in food procurement and processing, logistics, store design and maintenance, and natural food sales. Doutor Coffee Group segment operates directly managed and franchised coffee chains, and engages in coffee bean procurement, roasting and processing, store sales, wholesale to franchisees, royalty income and coffee product sales to convenience stores. Other segment engages in retail and wholesale activities related to restaurant businesses in Japan and overseas.
Directors
- Hirofumi Ohbayashi CHM (75)
- Masanori Hoshino PRE (61)
- Tomoyo Goda CEX (51)
- Masahiro Kanno CEX (62)
- Motoya Takebayashi MDR (55)
- Yasuyuki Tenma MDR (61)
- Kunio Hashimoto DRC (73)
- Kazuhiro Sekine DRC (55)
- Masaharu Kohno IND (72)
- Azuma Ohtsuka IND (76)
- Last Annual
- February 28th, 2026
- Last Interim
- August 31st, 2026
- Incorporated
- October 1st, 2007
- Public Since
- October 1st, 2007
- No. of Shareholders
- 58,437
- No. of Employees
- 2,892
- Sector
- Hotels & Entertainment Services
- Industry
- Consumer Cyclicals
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 42,074,412
- Address
- 10-11, Sarugaku-cho, SHIBUYA-KU, 150-0033
- Web
- https://www.dnh.co.jp/
- Phone
- +81 354599178
- Auditors
- KPMG AZSA LLC
Latest News for 3087
Upcoming Events for 3087
Q3 2027 Doutor Nichires Holdings Co Ltd Earnings Release
Dividend For 3087.T - 30.0000 JPY
Similar to 3087
Adventure
Tokyo Stock Exchange
Aeon Fantasy
Tokyo Stock Exchange
AGORA Hospitality
Tokyo Stock Exchange
AirTrip
Tokyo Stock Exchange
Amiyaki Tei
Tokyo Stock Exchange
FAQ
As of Today at 02:20 UTC, shares in Doutor Nichires Holdings are trading at ¥3,245. This share price information is delayed by 15 minutes.
Shares in Doutor Nichires Holdings last closed at ¥3,245 and the price had moved by +30.9% over the past 365 days. In terms of relative price strength the Doutor Nichires Holdings share price has underperformed the Nikkei 225 Index by -3.26% over the past year.
The overall consensus recommendation for Doutor Nichires Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Doutor Nichires Holdings dividend yield is 1.91% based on the trailing twelve month period.
Last year, Doutor Nichires Holdings paid a total dividend of ¥62, and it currently has a trailing dividend yield of 1.91%.Looking ahead, shares in Doutor Nichires Holdings are due to go ex-dividend on 2027-02-25 and the next dividend pay date is 2026-11-17.
Doutor Nichires Holdings are due to go ex-dividend on 2027-02-25 and the next dividend pay date is 2026-11-17. The historic dividend yield on Doutor Nichires Holdings shares is currently 1.91%.
To buy shares in Doutor Nichires Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥3,245, shares in Doutor Nichires Holdings had a market capitalisation of ¥137bn.
Here are the trading details for Doutor Nichires Holdings:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 3087
Based on an overall assessment of its quality, value and momentum Doutor Nichires Holdings is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Doutor Nichires Holdings is ¥3,300. That is 1.69% above the last closing price of ¥3,245.
Analysts covering Doutor Nichires Holdings currently have a consensus Earnings Per Share (EPS) forecast of ¥214 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Doutor Nichires Holdings. Over the past six months, its share price has outperformed the Nikkei 225 Index by +1.18%.
As of the last closing price of ¥3,245, shares in Doutor Nichires Holdings were trading +10.88% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Doutor Nichires Holdings PE ratio based on its reported earnings over the past 12 months is 14.06. The shares last closed at ¥3,245.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Doutor Nichires Holdings' management team is headed by:
- Hirofumi Ohbayashi - CHM
- Masanori Hoshino - PRE
- Tomoyo Goda - CEX
- Masahiro Kanno - CEX
- Motoya Takebayashi - MDR
- Yasuyuki Tenma - MDR
- Kunio Hashimoto - DRC
- Kazuhiro Sekine - DRC
- Masaharu Kohno - IND
- Azuma Ohtsuka - IND